The effect of decellularization of tracheal allografts on leukocyte infiltration and of recellularization on regulatory T cell recruitment

Biomaterials

Volumn 34, Issue 23, 2013, Pages 5821-5832

  Haykal, Siba ^a,b   Zhou, Yingzhe ^a   Marcus, Paula ^a   Salna, Michael ^a   Machuca, Tiago ^a   Hofer, Stefan O P ^b   Waddell, Thomas K ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Decellularization; Immune response; Mesenchymal stromal cells; Regulatory T cells; Tracheal transplantation

Indexed keywords

DECELLULARIZATION; IMMUNE RESPONSE; MESENCHYMAL STROMAL CELLS; REGULATORY T CELLS; TRACHEAL TRANSPLANTATION;

CARTILAGE; CELL PROLIFERATION; CELLS; CYTOLOGY; GENE EXPRESSION; IMMUNE SYSTEM; SCAFFOLDS (BIOLOGY); T-CELLS; TISSUE;

CELL ENGINEERING;

INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA1;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARTILAGE DEGENERATION; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DECELLULARIZED TRACHEAL ALLOGRAFT; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LEUKOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STROMA CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; STEM CELL; TRACHEAL EPITHELIAL PROGENITOR CELL;

ALLOGRAFTS; ANIMALS; CELL PROLIFERATION; COCULTURE TECHNIQUES; CYTOKINES; EPITHELIAL CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE ACTIVATION; MALE; MESENCHYMAL STROMAL CELLS; PHENOTYPE; SUS SCROFA; T-LYMPHOCYTES, REGULATORY; TRACHEA; TRANSPLANTATION, HETEROTOPIC; TRANSPLANTATION, HOMOLOGOUS;

ANIMALIA;

EID: 84877816061     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.04.044     Document Type: Article

References (46)

1. Grillo H.C. Surgery of the Trachea and Bronchi 2004, BC Decker Inc.
2. Gilbert T.W., Sellaro T.L., Badylak S.F. Decellularization of tissues and organs. Biomaterials 2006, 27:3675-3683.
3. Badylak S.F., Gilbert T.W. Immune response to biologic scaffold materials. Semin Immunol 2008, 20:109-116.
4. Macchiarini P., Jungebluth P., Go T., Asnaghi M.A., Rees L.E., Cogan T.A., et al. Clinical transplantation of a tissue-engineered airway. Lancet 2008, 372:2023-2030.
5. Haykal S., Soleas J.P., Salna M., Hofer S.O., Waddell T.K. Evaluation of the structural integrity and extracellular matrix components of tracheal allografts following cyclical decellularization techniques: comparison of three protocols. Tissue Eng Part C Methods 2012, 18:614-623.
6. Haykal S., Waddell T.K., Hofer S.O. Re: moving towards in situ tracheal regeneration: the bionic tissue engineered transplantation approach. JCell Mol Med 2010, 14(7):1877-1889. J Cell Mol Med. 2011;15:24-5.
7. Remlinger N.T., Czajka C.A., Juhas M.E., Vorp D.A., Stolz D.B., Badylak S.F., et al. Hydrated xenogeneic decellularized tracheal matrix as a scaffold for tracheal reconstruction. Biomaterials 2010, 31:3520-3526.
8. Gilbert T.W., Gilbert S., Madden M., Reynolds S.D., Badylak S.F. Morphologic assessment of extracellular matrix scaffolds for patch tracheoplasty in a canine model. Ann Thorac Surg 2008, 86:967-974. discussion-74.
9. Merguerian P.A., Reddy P.P., Barrieras D.J., Wilson G.J., Woodhouse K., Bagli D.J., et al. Acellular bladder matrix allografts in the regeneration of functional bladders: evaluation of large-segment (>24cm) substitution in a porcine model. BJU Int 2000, 85:894-898.
10. Brown A.L., Farhat W., Merguerian P.A., Wilson G.J., Khoury A.E., Woodhouse K.A. 22 week assessment of bladder acellular matrix as a bladder augmentation material in a porcine model. Biomaterials 2002, 23:2179-2190.
11. Bosch P., Pratt S.L., Stice S.L. Isolation, characterization, gene modification, and nuclear reprogramming of porcine mesenchymal stem cells. Biol Reprod 2006, 74:46-57.
12. Jungebluth P., Go T., Asnaghi A., Bellini S., Martorell J., Calore C., et al. Structural and morphologic evaluation of a novel detergent-enzymatic tissue-engineered tracheal tubular matrix. JThorac Cardiovasc Surg 2009, 138:586-593. discussion 92-3.
13. Go T., Jungebluth P., Baiguero S., Asnaghi A., Martorell J., Ostertag H., et al. Both epithelial cells and mesenchymal stem cell-derived chondrocytes contribute to the survival of tissue-engineered airway transplants in pigs. JThorac Cardiovasc Surg 2010, 139:437-443.
14. Conconi M.T., De Coppi P., Di Liddo R., Vigolo S., Zanon G.F., Parnigotto P.P., et al. Tracheal matrices, obtained by a detergent-enzymatic method, support invitro the adhesion of chondrocytes and tracheal epithelial cells. Transpl Int 2005, 18:727-734.
15. Liu Y., Nakamura T., Yamamoto Y., Matsumoto K., Sekine T., Ueda H., et al. Anew tracheal bioartificial organ: evaluation of a tracheal allograft with minimal antigenicity after treatment by detergent. ASAIO J 2000, 46:536-539.
16. Gui L., Chan S.A., Breuer C.K., Niklason L.E. Novel utilization of serum in tissue decellularization. Tissue Eng Part C Methods 2010, 16:173-184.
17. Ma R., Li M., Luo J., Yu H., Sun Y., Cheng S., et al. Structural integrity, ECM components and immunogenicity of decellularized laryngeal scaffold with preserved cartilage. Biomaterials 2013, 34:1790-1798.
18. Raghavan S.S., Woon C.Y., Kraus A., Megerle K., Choi M.S., Pridgen B.C., et al. Human flexor tendon tissue engineering: decellularization of human flexor tendons reduces immunogenicity invivo. Tissue Eng Part A 2012, 18:796-805.
19. Boer U., Lohrenz A., Klingenberg M., Pich A., Haverich A., Wilhelmi M. The effect of detergent-based decellularization procedures on cellular proteins and immunogenicity in equine carotid artery grafts. Biomaterials 2011, 32:9730-9737.
20. Ketchedjian A., Jones A.L., Krueger P., Robinson E., Crouch K., Wolfinbarger L., et al. Recellularization of decellularized allograft scaffolds in ovine great vessel reconstructions. Ann Thorac Surg 2005, 79:888-896. discussion 96.
21. O'Connor R.S., Hao X., Shen K., Bashour K., Akimova T., Hancock W.W., et al. Substrate rigidity regulates human T cell activation and proliferation. JImmunol 2012, 189:1330-1339.
22. Bastian F., Stelzmuller M.E., Kratochwill K., Kasimir M.T., Simon P., Weigel G. IgG deposition and activation of the classical complement pathway involvement in the activation of human granulocytes by decellularized porcine heart valve tissue. Biomaterials 2008, 29:1824-1832.
23. Keane T.J., Londono R., Turner N.J., Badylak S.F. Consequences of ineffective decellularization of biologic scaffolds on the host response. Biomaterials 2012, 33:1771-1781.
24. Bayrak A., Tyralla M., Ladhoff J., Schleicher M., Stock U.A., Volk H.D., et al. Human immune responses to porcine xenogeneic matrices and their extracellular matrix constituents invitro. Biomaterials 2010, 31:3793-3803.
25. Uccelli A., Moretta L., Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008, 8:726-736.
26. Salib R.J., Howarth P.H. Transforming growth factor-beta in allergic inflammatory disease of the upper airways: friend or foe?. Clin Exp Allergy 2009, 39:1128-1135.
27. Thompson N.L., Flanders K.C., Smith J.M., Ellingsworth L.R., Roberts A.B., Sporn M.B. Expression of transforming growth factor-beta 1 in specific cells and tissues of adult and neonatal mice. JCell Biol 1989, 108:661-669.
28. Kehrl J.H., Wakefield L.M., Roberts A.B., Jakowlew S., Alvarez-Mon M., Derynck R., et al. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. JExp Med 1986, 163:1037-1050.
29. McKarns S.C., Schwartz R.H. Distinct effects of TGF-beta 1 on CD4+ and CD8+ T cell survival, division, and IL-2 production: a role for T cell intrinsic Smad3. JImmunol 2005, 174:2071-2083.
30. Smyth M.J., Strobl S.L., Young H.A., Ortaldo J.R., Ochoa A.C. Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta. JImmunol 1991, 146:3289-3297.
31. Baiguera S., Jungebluth P., Mazzanti B., Macchiarini P. Mesenchymal stromal cells for tissue-engineered tissue and organ replacements. Transpl Int 2012, 25:369-382.
32. Jungebluth P., Bader A., Baiguera S., Moller S., Jaus M., Lim M.L., et al. The concept of invivo airway tissue engineering. Biomaterials 2012, 33:4319-4326.
33. Badylak S.F., Valentin J.E., Ravindra A.K., McCabe G.P., Stewart-Akers A.M. Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng Part A 2008, 14:1835-1842.
34. Liu G.F., He Z.J., Yang D.P., Han X.F., Guo T.F., Hao C.G., et al. Decellularized aorta of fetal pigs as a potential scaffold for small diameter tissue engineered vascular graft. Chin Med J (Engl) 2008, 121:1398-1406.
35. Meyer S.R., Nagendran J., Desai L.S., Rayat G.R., Churchill T.A., Anderson C.C., et al. Decellularization reduces the immune response to aortic valve allografts in the rat. JThorac Cardiovasc Surg 2005, 130:469-476.
36. Wilshaw S.P., Kearney J., Fisher J., Ingham E. Biocompatibility and potential of acellular human amniotic membrane to support the attachment and proliferation of allogeneic cells. Tissue Eng Part A 2008, 14:463-472.
37. Engela A.U., Baan C.C., Dor F.J., Weimar W., Hoogduijn M.J. On the interactions between mesenchymal stem cells and regulatory T cells for immunomodulation in transplantation. Front Immunol 2012, 3:126.
38. Casiraghi F., Azzollini N., Cassis P., Imberti B., Morigi M., Cugini D., et al. Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. JImmunol 2008, 181:3933-3946.
39. Ge W., Jiang J., Arp J., Liu W., Garcia B., Wang H. Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3-dioxygenase expression. Transplantation 2010, 90:1312-1320.
40. Ge W., Jiang J., Baroja M.L., Arp J., Zassoko R., Liu W., et al. Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance. Am J Transplant 2009, 9:1760-1772.
41. Curotto de Lafaille M.A., Lafaille J.J., Graca L. Mechanisms of tolerance and allergic sensitization in the airways and the lungs. Curr Opin Immunol 2010, 22:616-622.
42. Zhao L., Hantash B.M. TGF-beta1 regulates differentiation of bone marrow mesenchymal stem cells. Vitam Horm 2011, 87:127-141.
43. Bommireddy R., Doetschman T. TGFbeta1 and Treg cells: alliance for tolerance. Trends Mol Med 2007, 13:492-501.
44. Li M.O., Wan Y.Y., Sanjabi S., Robertson A.K., Flavell R.A. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 2006, 24:99-146.
45. Hawrylowicz C.M., O'Garra A. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat Rev Immunol 2005, 5:271-283.
46. O'Garra A., Barrat F.J., Castro A.G., Vicari A., Hawrylowicz C. Strategies for use of IL-10 or its antagonists in human disease. Immunol Rev 2008, 223:114-131.